GlassScriptPhysician profile
Tanya S Pratt
NPI 1760420715
$1,278.66
in general payments reported to CMS, 2019-2025
22 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $30.59 · 2021: $109 · 2022: $329 · 2023: $153 · 2024: $116 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $301.99 | 2019-2022 | |
| Abbvie INC. | $151.63 | 2021-2024 | |
| Medical Device Business Services, INC. | $125.00 | 2022 | |
| Roche Diagnostics Corporation | $101.36 | 2019-2020 | |
| Biogen, INC. | $75.26 | 2024-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $74.58 | 2019-2023 | Gardasil 9 |
| Mayne Pharma Commercial LLC | $66.09 | 2023-2024 | |
| Organon LLC | $54.31 | 2023-2025 | Jada System, Nexplanon |
| Hologic Sales and Service, LLC | $53.27 | 2019-2025 | Fetal Fibronectin Enzyme Immunoassay |
| Daiichi Sankyo INC. | $36.39 | 2019 | |
| Exeltis, USA INC. | $34.18 | 2024 | Slynd |
| Cranial Technologies, INC | $28.00 | 2023 | Doc Band |
| Pacira Pharmaceuticals Incorporated | $27.20 | 2019 | |
| Abbott Laboratories | $23.00 | 2019 | |
| Pfizer INC. | $20.33 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $18.60 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.64 | 2022 | |
| Ferring Pharmaceuticals INC. | $16.16 | 2019 | |
| Millicent US INC | $15.81 | 2025 | Femlyv |
| Myovant Sciences INC. | $15.16 | 2022 | |
| Evofem Biosciences, INC. | $12.14 | 2022 | |
| Allergan, INC. | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanya Pratt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.